We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$4.7B
AUM Growth
-$238M
Cap. Flow
-$118M
Cap. Flow %
-2.51%
Top 10 Hldgs %
27.49%
Holding
1,425
New
528
Increased
233
Reduced
492
Closed
45

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$33.5M
2
AMT icon
American Tower
AMT
+$31.3M
3
EQIX icon
Equinix
EQIX
+$12.7M
4
SBAC icon
SBA Communications
SBAC
+$8.56M
5
LAMR icon
Lamar Advertising Co
LAMR
+$6.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$41.1M
2
MSFT icon
Microsoft
MSFT
+$34M
3
AMZN icon
Amazon
AMZN
+$23.1M
4
OUT icon
Outfront Media
OUT
+$17.7M
5
UNIT
Uniti Group
UNIT
+$13.8M

Sector Composition

Rank Sector Weight
1 Technology 21.72%
2 Real Estate 17.45%
3 Consumer Discretionary 10.45%
4 Healthcare 9.89%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
1201
Agenus
AGEN
$275M
$30K ﹤0.01%
+385
New +$30K
EC icon
1202
Ecopetrol
EC
$32.5B
$30K ﹤0.01%
3,044
+1,512
+99% +$17.2K
RCUS icon
1203
Arcus Biosciences
RCUS
$3.4B
$30K ﹤0.01%
+1,741
New +$38.9K
YMAB
1204
DELISTED
Y-mAbs Therapeutics
YMAB
$30K ﹤0.01%
+775
New +$30.8K
ANIK icon
1205
Anika Therapeutics
ANIK
$202M
$29K ﹤0.01%
+807
New +$29.1K
FMX icon
1206
Fomento Económico Mexicano
FMX
$43.5B
$29K ﹤0.01%
512
+246
+92% +$14.4K
KSA icon
1207
iShares MSCI Saudi Arabia ETF
KSA
$622M
$29K ﹤0.01%
960
+450
+88% +$12.7K
CPRX
1208
DELISTED
Catalyst Pharmaceutical
CPRX
$28K ﹤0.01%
+9,345
New +$36.5K
DVAX
1209
DELISTED
Dynavax Technologies
DVAX
$28K ﹤0.01%
+6,469
New +$46.2K
MGNX icon
1210
MacroGenics
MGNX
$245M
$28K ﹤0.01%
+1,113
New +$30.4K
ANAB icon
1211
AnaptysBio
ANAB
$1.54B
$27K ﹤0.01%
+1,862
New +$33.6K
ATNX
1212
DELISTED
Athenex, Inc. Common Stock
ATNX
$27K ﹤0.01%
+111
New +$26.7K
BAH icon
1213
Booz Allen Hamilton
BAH
$8.78B
$26K ﹤0.01%
316
-47
-13% -$3.85K
IGMS
1214
DELISTED
IGM Biosciences
IGMS
$26K ﹤0.01%
+355
New +$21K
MANT
1215
DELISTED
Mantech International Corp
MANT
$26K ﹤0.01%
372
-10
-3% -$707
SPPI
1216
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$25K ﹤0.01%
+6,108
New +$23.2K
MRSN
1217
DELISTED
Mersana Therapeutics
MRSN
$24K ﹤0.01%
+52
New +$26.3K
VVX icon
1218
V2X
VVX
$2.82B
$24K ﹤0.01%
641
+101
+19% +$4.39K
TBIO
1219
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$24K ﹤0.01%
+1,764
New +$27.2K
GOSS icon
1220
Gossamer Bio
GOSS
$100M
$23K ﹤0.01%
+1,848
New +$24.5K
NBLX
1221
DELISTED
Noble Midstream Partners LP
NBLX
$22K ﹤0.01%
2,939
+520
+21% +$4.38K
RYTM icon
1222
Rhythm Pharmaceuticals
RYTM
$7.41B
$21K ﹤0.01%
+951
New +$21.8K
ALEC icon
1223
Alector
ALEC
$169M
$19K ﹤0.01%
+1,828
New +$29.6K
PBFX
1224
DELISTED
PBF LOGISTICS LP
PBFX
$19K ﹤0.01%
2,310
+300
+15% +$2.83K
ARDX icon
1225
Ardelyx
ARDX
$1.25B
$18K ﹤0.01%
+3,360
New +$20.2K

Similar funds

Pacer Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Pacer Advisors held 1,425 positions worth $4.7B, down 4.8% from $4.94B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Pacer Advisors's Q3 2020 filing shows 528 new, 233 increased, 492 reduced and 45 closed positions. Its largest new stake was iShares MSCI South Korea ETF: 103,528 shares worth $6.76M. The largest sale was Apple, an estimated $41.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Real Estate and Consumer Discretionary.

  • Pacer Advisors's largest Q3 2020 buy was iShares MSCI South Korea ETF: 103,528 shares worth $6.76M.
  • Pacer Advisors added most to Crown Castle in Q3 2020, an estimated $33.5M increase.
  • Pacer Advisors's biggest Q3 2020 reduction was Apple, cutting an estimated $41.1M.
  • Pacer Advisors fully exited Dell in Q3 2020, selling an estimated $4.74M.
  • Pacer Advisors's ten largest holdings make up 27% of its $4.7B portfolio in Q3 2020.
  • Pacer Advisors opened 528 new positions and closed 45 in Q3 2020.
  • Pacer Advisors's portfolio value fell 4.8% quarter-over-quarter to $4.7B.

Based on Pacer Advisors's 13F filing for Q3 2020, filed 19 Oct 2020.